Incredibly proud to see Dr Fisher presenting her research at the AACR annual conference. Understanding precancer biology is crucial for improving early detection, and preventing early cancer development and progression. #AACR25

AACR.. over and out! Great couple of days in Chicago, brilliant to catch up with so many collaborators and make new connections. Coming home brimming with new ideas to take into our early detection, INCISE , MRC NMGN Cancer Cluster & CRC-STARS programmes #AACR25

Better late than ever. Awesome to catch up with colleagues and friends at #AACR25! Philip Dunne

🇬🇧PRIME-RT results ESTRO today: Durvalumab anti-PDL1+SC/LC TNT in #rectalcancer 52% of pts had CR (pCR/cCR) @ 6mth post-EOT in LARC ⬆️CR rate w SCRT-Durv - may reflect divergent immune effects of RT on TME Privileged to be part of incredible ‘Top trials’ session#ESTRO25

The PRIME-RT team comprises fantastic clinical/ CTU teams from across the UK - University of Aberdeen, Oxford The Christie NHS, NHS Ayrshire & Arran and University of Glasgow UofG Cancer Sciences Queen's University Belfast 🎓 We are especially appreciative of the patients who contributed time and energy to be part of the trial.

Next step is translational analysis of serial tumour samples to understand 1. Why tumours respond more or less than others 2. how RT/anti-PDL1 impacts the TME and response evolution. 👀Watch this space Nigel B. Jamieson Joanne Edwards Owen Sansom 🏳️‍🌈 ACRCelerate CRUK Scotland Inst

Can molecular biomarkers improve colorectal polyp surveillance? Our new preprint shows that ARID1A expression + copy number alterations in KMT2C, SMG1 and TRAF7 enhance risk stratification beyond current BSG2020 guidelines doi.org/10.1101/2025.0… INCISE Beatson Cancer Charity

Exciting news for rectal cancer patients - results from a Glasgow clinical trial provide new hope heraldscotland.com/news/25136553.…

Sunshine and science in Glasgow today at the CRC-STARS kick off meeting in CRUK Scotland Inst Excellent presention from Raheleh Amirkhah charting phenotypic evolution during cancer development and progression, and how best we can use preclinical models of cancer to improve patient outcomes

Philip Dunne CRUK Scotland Inst The Patrick G Johnston Centre for Cancer Research ACRCelerate MRC NMGN Cancer Cluster Owen Sansom 🏳️‍🌈 Simon Leedham Thrilled to share our work at the CRC-STARS kick-off meeting. Grateful to be part of this fantastic program and inspired by the many excellent talks. Excited for the discoveries ahead and the chance to contribute to impactful research!

After 4 days of blistering sunshine on the Ayrshire coast with the family, heading back on the ferry to the homeland this evening. Looking out at the 12 mile gap that is the closest points separating Scotland & Ireland. Absolutely love these two places ☀️☘️🏴󠁧󠁢󠁳󠁣󠁴󠁿☀️

HUGE congratulations to Scott Kopetz MD Anderson Cancer Center who will lead a multi-institutional consortium (CRC-ASCEND) on implementing adaptive clinical trials in #ColorectalCancer. Kudos to the whole team, including oncologists, program managers and patient advocates. A.n.n.

Thanks Queen's University Belfast 🎓 Prof Helen Coleman for inviting Amanda J Cross to give the Charlotte Jackson Gift Lecture today. A great opportunity to share our Cancer Research UK funded work on the early detection of #BowelCancer & how our findings are influencing policy and patient care #CancerResearch

We caught up with researchers from PGJCCR's Philip Dunne Lab about their trip to April's AACR Conference in Chicago. Natalie Fisher & Sid explained how it connected them with collaborators and set out to shape the direction of future research: qub.ac.uk/research-centr…

Thank you to CRUK Scotland Inst and Philip Dunne for a wonderful experience in Scotland for #BICC2025. Congratz to Harsimran Kaur for receiving the outstanding poster award!

Great to be asked to speak as part of Glasgow Science Festival last week about "Poop, Polyps & Pathology" - thank you to my audience for an engaging conversation about bowel cancer screening! 🔬🧫🧬